Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
XT Venture Capital, the venture arm of XT Group, is an Israeli investment firm founded in 1997. It provides capital, strategic advice, and comprehensive support to early-growth Israeli startups with the potential to become category leaders. The firm has a strong track record of over 100 direct investments, including more than 30 IPOs and M&As.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Cyber Security1
Q&A
- What is XT Investments' most significant exit?
- XT Investments achieved a significant exit in March 2020 with the acquisition of Checkmarx by Hellman & Friedman for $1.15 billion.
- Which sectors does XT Investments focus on?
- XT Investments has shown a focus on the Health Tech & Life Sciences and Cyber Security sectors, with portfolio companies in both.
- Can you name some of XT Investments' notable portfolio companies?
- XT Investments' portfolio includes Angioslide, which develops embolic capture angioplasty devices, and Checkmarx, a cloud-native AppSec platform that was acquired in 2020.
- What is the typical investment range for XT Investments?
- XT Investments typically invests in the range of $3 million to $8.25 million.
- When did XT Investments make its most recent investment according to available data?
- XT Investments made an investment in May 2015, which was a D Round.
- What funding stages has XT Investments participated in?
- XT Investments has participated in various funding stages, including B Round, C Round, D Round, and E Round.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1997 |
|---|